AstraZeneca And Shionogi Launch Arteriosclerosis Awareness Campaign In Japan
This article was originally published in PharmAsia News
AstraZeneca and Shionogi will jointly launch a public relations campaign to raise awareness for arteriosclerosis in Japan. The two established a Web site July 21. The companies aim to educate on the lack of self noticeable symptoms of the disease and urge more people to have a medical checkup. (Click here for more - Japanese language
You may also be interested in...
Partners say they are encouraged by new overall response data from early trials for the two drugs together in kidney and liver cancer, presented to ASCO.
The Democratic Primary focused heavily on the idea of ‘Medicare for All,’ but the emergence of former Vice President Biden as the party standard bearer – and the overwhelming impact of the COVID-19 outbreak – suggests a very different theme for the national campaign.
In a 1 June speech before the Alliance For a Stronger FDA, US FDA commissioner Stephen Hahn stressed the agency’s vigilance in guarding against consumer use of flawed COVID-19 products. He also made comments about the need for doctors to communicate more with patients. See what he said about the use of telehealth here.